About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Spatial Analysis and Validation of Glioblastoma on 7 T MRI

Spatial Analysis and Validation of Glioblastoma on 7 T MRI

NCT02062372·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Maastricht Radiation Oncology

With

The Limburg University Fund

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Supratentorial tumour
Suspected GBM on diagnostic MRI
Eligible for biopsy
Minimum age 18 years or older
World Health Organization (WHO) Performance scale ≤2
American Society of Anaesthesiologist (ASA) class ≤ 3
Understanding of the Dutch language
Ability to comply to study procedure

You may not be if

Recurrent tumour
Tumour location deemed unfit for extra biopsies
Prior radiotherapy to the skull
Prior chemotherapy
World Health Organization (WHO) Performance scale ≥ 3
American Society of Anaesthesiologist (ASA) class ≥ 3
Eligibility for immediate debulking
Contra-indications for gadolinium
Contra-indications for the MRI

The record

StatusTerminated

PhaseNo phase

Taking part5

StartedDec 2014

UpdatedAug 17, 2018

Conditions

Where1

Maastricht Radiation Oncology (MAASTRO clinic)
Maastricht, Limburg, Netherlands